NextCure Statistics

Total Valuation

NextCure has a market cap or net worth of $43.92 million. The enterprise value is -$57.87 million.

Market Cap	43.92M
Enterprise Value	-57.87M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

NextCure has 27.97 million shares outstanding. The number of shares has increased by 0.33% in one year.

Shares Outstanding	27.97M
Shares Change (YoY)	+0.33%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	8.84%
Owned by Institutions (%)	50.25%
Float	20.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.38, with a Debt / Equity ratio of 0.05.

Current Ratio	16.38
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.00% and return on invested capital (ROIC) is -56.19%.

Return on Equity (ROE)	-47.00%
Return on Assets (ROA)	-42.60%
Return on Capital (ROIC)	-56.19%
Revenue Per Employee	n/a
Profits Per Employee	-$764,915
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.88% in the last 52 weeks. The beta is 0.39, so NextCure's price volatility has been lower than the market average.

Beta (1Y)	0.39
52-Week Price Change	+2.88%
50-Day Moving Average	1.72
200-Day Moving Average	1.45
Relative Strength Index (RSI)	42.08
Average Volume (30 Days)	282,569

Short Selling Information

The latest short interest is 993,759, so 3.55% of the outstanding shares have been sold short.

Short Interest	993,759
Short Previous Month	839,685
Short % of Shares Out	3.55%
Short % of Float	4.78%
Short Ratio (days to cover)	1.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-67.64M
Pretax Income	-62.72M
Net Income	-62.72M
EBITDA	-58.47M
EBIT	-62.72M
Earnings Per Share (EPS)	-$2.25

Full Income Statement

Balance Sheet

The company has $108.30 million in cash and $5.95 million in debt, giving a net cash position of $102.35 million or $3.66 per share.

Cash & Cash Equivalents	108.30M
Total Debt	5.95M
Net Cash	102.35M
Net Cash Per Share	$3.66
Equity / Book Value	114.42M
Book Value Per Share	4.09
Working Capital	105.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.97 million and capital expenditures -$820,000, giving a free cash flow of -$53.79 million.

Operating Cash Flow	-52.97M
Capital Expenditures	-820,000
Free Cash Flow	-53.79M
FCF Per Share	-$1.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.33%
Shareholder Yield	-0.33%
Earnings Yield	-141.02%
FCF Yield	-120.95%

Analyst Forecast

The average price target for NextCure is $6.00, which is 280.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	280.23%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.60%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2